The execution of Kelly Gissendaner was postponed just hours before it was scheduled to take place on March 2, after correctional officials in Georgia became concerned that the lethal injection chemicals appeared cloudy. “The Department of Corrections immediately consulted with a pharmacist, and in an abundance of caution, Inmate Gissendaner’s execution has been postponed,” the Department of Corrections said in a statement. Georgia is one of several states that have turned to compounding pharmacies for lethal injection drugs after large pharmaceutical companies blocked the use of their products in executions. A state secrecy law shields the identity of the drug preparer. Gissendaner’s lawyers had filed appeals with the U.S. Supreme Court arguing that the lack of transparency could allow the use of drugs that were unreliable. Georgia has not yet announced a new execution date. Gissendaner’s execution was previously moved from February 25 to March 2 due to a winter storm.

(T. Connor, “Georgia Execution of Kelly Gissendaner Postponed for Drug Issue,” NBC News, March 2, 2015.) See Lethal Injection and Women.